Clinical and Biological Characteristics of Hidradenitis Suppurativa

University of California, San Francisco1,000 enrolled

Overview

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Hidradenitis Suppurativa

Eligibility

Sex: ALLMin age: 13 YearsHealthy volunteers:

Medical Language ↔ Plain English

Hidradenitis Suppurativa Patients Inclusion Criteria: 1. Age 13 years or older 2. Diagnosis of HS clinically-confirmed by a physician Exclusion Criteria: 1\. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent. Healthy Volunteer Inclusion Criteria: 1. No history of chronic skin conditions 2. No recent history of antibiotic use Exclusion Criteria: 1\. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.

Locations (1)

University of California, San Francisco

San Francisco, California, United States

Outcomes

Primary Outcomes

The primary aim of this study is to identify clinical and biologic characteristics of hidradenitis suppurativa.

Time frame: 2016-2026

Secondary Outcomes

Secondary aims include correlating alterations in clinical and biological characteristics with disease status, and identifying genetic variants that predict disease progression or response to therapy.